Your search returned 29 results.

Results
	21.	Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. [electronic resource] by Rexer, B N Ham, A-J L Rinehart, C Hill, S Granja-Ingram, N de Matos González-Angulo, A M Mills, G B Dave, B Chang, J C Liebler, D C Arteaga, C L Producer: 20111122 In: Oncogene vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer. [electronic resource] by Dillon, L M Bean, J R Yang, W Shee, K Symonds, L K Balko, J M McDonald, W H Liu, S Gonzalez-Angulo, A M Mills, G B Arteaga, C L Miller, T W Producer: 20151009 In: Oncogene vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer. [electronic resource] by Liedtke, C Broglio, K Moulder, S Hsu, L Kau, S-W Symmans, W F Albarracin, C Meric-Bernstam, F Woodward, W Theriault, R L Kiesel, L Hortobagyi, G N Pusztai, L Gonzalez-Angulo, A M Producer: 20100125 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	24.	Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers. [electronic resource] by Mazouni, C Kau, S-W Frye, D Andre, F Kuerer, H M Buchholz, T A Symmans, W F Anderson, K Hess, K R Gonzalez-Angulo, A M Hortobagyi, G N Buzdar, A U Pusztai, L Producer: 20070802 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	25.	Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer. [electronic resource] by Kim, M M Allen, P Gonzalez-Angulo, A M Woodward, W A Meric-Bernstam, F Buzdar, A U Hunt, K K Kuerer, H M Litton, J K Hortobagyi, G N Buchholz, T A Mittendorf, E A Producer: 20140422 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	26.	Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. [electronic resource] by Pradeep, C-R Köstler, W J Lauriola, M Granit, R Z Zhang, F Jacob-Hirsch, J Rechavi, G Nair, H B Hennessy, B T Gonzalez-Angulo, A M Tekmal, R R Ben-Porath, I Mills, G B Domany, E Yarden, Y Producer: 20120504 In: Oncogene vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	27.	A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer. [electronic resource] by Bastos, E P Brentani, H Pereira, C A B Polpo, A Lima, L Puga, R D Pasini, F S Osorio, C A B T Roela, R A Achatz, M I Trapé, A P Gonzalez-Angulo, A M Brentani, M M Producer: 20170711 In: PloS one vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	28.	Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes. [electronic resource] by Masuda, H Brewer, T M Liu, D D Iwamoto, T Shen, Y Hsu, L Willey, J S Gonzalez-Angulo, A M Chavez-MacGregor, M Fouad, T M Woodward, W A Reuben, J M Valero, V Alvarez, R H Hortobagyi, G N Ueno, N T Producer: 20150330 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	29.	Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†. [electronic resource] by Gonzalez-Angulo, A M Akcakanat, A Liu, S Green, M C Murray, J L Chen, H Palla, S L Koenig, K B Brewster, A M Valero, V Ibrahim, N K Moulder-Thompson, S Litton, J K Tarco, E Moore, J Flores, P Crawford, D Dryden, M J Symmans, W F Sahin, A Giordano, S H Pusztai, L Do, K-A Mills, G B Hortobagyi, G N Meric-Bernstam, F Producer: 20150121 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)